GRAHAM RICHARD A
SEC CIK 1820036 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TBPH | Theravance Biopharma, Inc. | SVP, RESEARCH, DEVELOPMENT | 314.9K | — | $446.9K | 28 | 2021-08-20 | 2024-02-20 |
Most active insiders at TBPH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Samaha Eli | 10% | — | $5.91M |
| 2 | BROSHY ERAN | Dir | — | $2.47M |
| 3 | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | — | $1.46M |
| 4 | Miller Aine | SVP, DEV, HEAD OF IRE OFFICE | — | — |
| 5 | Grimaud Brett A. | SVP, GEN COUNSEL AND Sec | — | — |
| 6 | Sawaf Aziz | SVP, CFO | — | — |
| 7 | GRAY SUSANNAH | Dir | — | — |
| 8 | O'Connor Donal | Dir | — | — |
| 9 | Smaldone Alsup Laurie | Dir | — | — |
| 10 | Winningham Rick E | CEO, Dir | — | — |
GRAHAM RICHARD A made no open-market trades at TBPH in the last 12 months.
Transactions 28
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-22 | 2024-02-20 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | F - Tax | $8.92 | -19.3K | 314.9K | -6% | -$172.1K | |
| 2023-11-22 | 2023-11-20 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | F - Tax | $10.37 | -12.6K | 334.2K | -4% | -$131.0K | |
| 2023-11-16 | 2023-11-14 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $10.22 | -2,482 | 346.8K | -0.7% | -$25.4K | |
| 2023-11-01 | 2023-10-30 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | A - Grant | $0.00 | +15.0K | 349.3K | +4% | $0 | |
| 2023-10-18 | 2023-10-16 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $9.03 | -2,482 | 334.3K | -0.7% | -$22.4K | |
| 2023-09-18 | 2023-09-14 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $9.89 | -2,482 | 336.8K | -0.7% | -$24.5K | |
| 2023-08-22 | 2023-08-20 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | F - Tax | $9.70 | -10.5K | 339.3K | -3% | -$101.5K | |
| 2023-08-15 | 2023-08-11 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $9.99 | -2,322 | 349.7K | -0.7% | -$23.2K | |
| 2023-07-18 | 2023-07-14 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $9.84 | -2,322 | 352.1K | -0.7% | -$22.8K | |
| 2023-06-16 | 2023-06-14 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $10.69 | -2,322 | 354.4K | -0.7% | -$24.8K | |
| 2023-05-23 | 2023-05-20 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | F - Tax | $11.21 | -10.5K | 356.7K | -3% | -$117.3K | |
| 2023-05-17 | 2023-05-15 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $11.26 | -2,322 | 367.2K | -0.6% | -$26.1K | |
| 2023-04-18 | 2023-04-14 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $11.88 | -2,323 | 369.5K | -0.6% | -$27.6K | |
| 2023-03-16 | 2023-03-14 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $10.32 | -2,323 | 371.8K | -0.6% | -$24.0K | |
| 2023-03-08 | 2023-03-06 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $10.05 | -2,323 | 374.1K | -0.6% | -$23.3K | |
| 2023-03-03 | 2023-03-01 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | A - Grant | $0.00 | +75.0K | 376.5K | +25% | $0 | |
| 2023-02-22 | 2023-02-20 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | F - Tax | $10.44 | -12.1K | 301.5K | -4% | -$125.9K | |
| 2022-12-05 | 2022-12-01 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $10.73 | -2,084 | 313.5K | -0.7% | -$22.4K | |
| 2022-11-22 | 2022-11-20 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | F - Tax | $10.85 | -27.4K | 315.6K | -8% | -$296.7K | |
| 2022-11-17 | 2022-11-16 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | F - Tax | $11.20 | -2,800 | 343.0K | -0.8% | -$31.4K | |
| 2022-08-23 | 2022-08-19 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, DEVELOPMENT | F - Tax | $9.34 | -19.0K | 345.8K | -5% | -$177.4K | |
| 2022-08-18 | 2022-08-16 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, DEVELOPMENT | S - Sale | $9.71 | -4,906 | 364.7K | -1% | -$47.6K | |
| 2022-08-11 | 2022-08-09 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, DEVELOPMENT | S - Sale | $8.79 | -15.1K | 369.7K | -4% | -$132.6K | |
| 2022-05-24 | 2022-05-20 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, DEVELOPMENT | F - Tax | $8.74 | -3,947 | 384.7K | -1% | -$34.5K | |
| 2022-02-23 | 2022-02-18 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, DEVELOPMENT | F - Tax | $9.61 | -20.4K | 388.7K | -5% | -$195.8K | |
| 2021-12-06 | 2021-12-02 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, Development | A - Grant | $0.00 | +240.0K | 409.1K | +142% | $0 | |
| 2021-11-23 | 2021-11-19 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, DEVELOPMENT | F - Tax | $8.36 | -4,263 | 169.1K | -2% | -$35.6K | |
| 2021-08-24 | 2021-08-20 | TBPH | Theravance Biopharma, Inc. | GRAHAM RICHARD A | SVP, Development | F - Tax | $14.05 | -6,819 | 173.2K | -4% | -$95.8K |
Purchase Sale Sale after option exercise All abbreviations